ReviewDrug development research2026

Advances in N- and S-Heterocycles as c-Jun-N-Terminal Kinase 3 Inhibitors for Alzheimer's Disease Treatment.

Parul Yadav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.